Alchemab
PrivateLast Round
Series A
Extension
Sep 10, 2025
Total Funding Raised
$114M
Company Overview
Alchemab Therapeutics is a biotechnology company that develops natural protective antibodies aimed at preventing hard-to-treat diseases through a transformative, function-first approach utilizing complementary processes and technologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alchemab Comps
Public and private peers based on sector, stage, and business model.
Alchemab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 10, 2025 | ||||
| Series A | Apr 15, 2021 |
Key People
Founding team and executive leadership
Alchemab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A Extension, Series A |
| SV Health Investors | Series A, Series A Extension, Seed |
| DCVC Bio | Seed, Series A Extension |
| Camford Capital | Series A |
| Lightstone Ventures | Series A, Series A Extension |
| Ono Venture Investment, Inc. | Series A Extension |
| OVI Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Dr. Ulrich Wendt appointed as Chief Business Officer.
- Sep 10, 2025
Phase I trial started for antibody candidate ATLX-1282.
Alchemab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alchemab's valuation, stock price, and market status.
